Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 2/20 | 0.71 |
| ▸ | PTGS1 | P23219 | 6/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.70 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.70 |
| ▸ | TTR | P02766 | 4/20 | 0.70 |
| ▸ | MEN1 | O00255 | 3/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.70 |
| ▸ | TP53 | P04637 | 3/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 3/20 | 0.70 |
| ▸ | HPGD | P15428 | 3/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.70 |
| ▸ | LMNA | P02545 | 3/20 | 0.70 |
| ▸ | CA12 | O43570 | 2/20 | 0.70 |
| ▸ | CA1 | P00915 | 2/20 | 0.70 |
| ▸ | CA2 | P00918 | 2/20 | 0.70 |
| ▸ | CA3 | P07451 | 2/20 | 0.70 |
| ▸ | CA4 | P22748 | 2/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pinosylvin SCHEMBL454262 | 1.00 | LCK (0.71) | LCKPTGS1KDM4EPTGS2TTR | |
| Pinosylvin SCHEMBL2237657 | 1.00 | LCK (0.71) | LCKPTGS1KDM4EPTGS2TTR | |
| Pinosylvin SCHEMBL9419839 | 1.00 | LCK (0.71) | LCKPTGS1KDM4EPTGS2TTR | |
| Pinosylvin SCHEMBL3940383 | 1.00 | LCK (0.71) | LCKPTGS1KDM4EPTGS2TTR | |
| Pinosylvin SCHEMBL20455852 | 1.00 | LCK (0.71) | LCKPTGS1KDM4EPTGS2TTR | |
| Pinosylvin SCHEMBL7075363 | 1.00 | LCK (0.71) | LCKPTGS1KDM4EPTGS2TTR | |
| Pinosylvin SCHEMBL1586341 | 0.93 | KDM4E (0.72) | LCKPTGS1KDM4EPTGS2TTR | |
| Resveratrol SCHEMBL721421 | 0.93 | KDM4E (0.83) | LCKPTGS1KDM4EPTGS2TTR | |
| Resveratrol SCHEMBL7529004 | 0.93 | KDM4E (0.83) | LCKPTGS1KDM4EPTGS2TTR | |
| Pinosylvin SCHEMBL27484375 | 0.93 | KDM4E (0.72) | LCKPTGS1KDM4EPTGS2TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704801-A1 | COMPOSITIONS COMPRISING NIACINAMIDE AND RESVERATROL SALICYLATE | ELC Management LLC (US) | 2026-03-11 | — | — | EP | claimed |
| CN-118948982-A | Compositions comprising alpinia and other plant extracts for improving joint health and treating arthritis | 尤尼根公司 | 2024-11-15 | — | — | CN | claimed |
| WO-2024229025-A1 | COMPOSITIONS COMPRISING NIACINAMIDE AND RESVERATROL SALICYLATE | ELC MANAGEMENT LLC (US) | 2024-11-07 | — | — | WO | claimed |
| EP-4436538-A1 | COSMETIC OR PHARMACEUTICAL PREPARATION FOR SKIN CARE AND IMPROVING SKIN CONDITION | Merryvital AG (CH) | 2024-10-02 | — | — | EP | claimed |
| US-20240263203-A1 | RECOMBINANT HOST CELLS WITH IMPROVED PRODUCTION OF TETRAKETIDE DERIVATIVES | IPTECTOR ASSETS APS (DK) | 2024-08-08 | — | — | US | claimed |
| CN-118401224-A | Cosmetic or cosmeceutical product for skin care and improving skin condition | 迈瑞维拓股份公司 | 2024-07-26 | — | — | CN | claimed |
| CN-117801688-A | Flexible adhesive material and preparation method thereof | 南通市锋芒复合材料科技有限公司 | 2024-04-02 | — | — | CN | claimed |
| WO-2023094852-A1 | COSMETIC OR PHARMACEUTICAL PREPARATION FOR SKIN CARE AND IMPROVING SKIN CONDITION | MERRYVITAL AG (CH) | 2023-06-01 | — | — | WO | claimed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| CN-115515614-A | Compositions comprising extracts of alpinia and other plants for improving joint health and treating arthritis | 尤尼根公司 | 2022-12-23 | — | — | CN | claimed |
| EP-2005941-A2 | Cellular rejuvenation compounds | Henkel AG & Co. KGaA (DE) | 2008-12-24 | — | — | EP | claimed |
| US-20080139650-A1 | Fungicidally Active Polymer Dispersions And Use Thereof | CELANESE EMULSIONS GMBH (DE) | 2008-06-12 | — | — | US | claimed |
| EP-1796459-A2 | FUNGICIDALLY ACTIVE POLYMER DISPERSIONS AND USE THEREOF | Celanese Emulsions GmbH (DE) | 2007-06-20 | — | — | EP | claimed |
| WO-2006034762-A2 | FUNGICIDALLY ACTIVE POLYMER DISPERSIONS AND USE THEREOF | CELANESE EMULSIONS GMBH (DE) | 2006-04-06 | — | — | WO | claimed |
| US-20020198159-A1 | USE OF STILBENE DERIVATIVES SUBSTITUTED IN POSITION 3 AS DEODORANT ACTIVE AGENTS IN COSMETIC COMPOSITIONS | L'OREAL S.A. | 2002-12-26 | — | — | US | claimed |
| US-6407142-B1 | APPLYING 3,5-DIHYDROXYSTILBENE TO INHIBIT CORYNEBACTERIUM | L'OREAL S.A. (FR) | 2002-06-18 | — | — | US | claimed |
| US-20020028852-A1 | Resveratrol analogs for prevention of disease | RUTGERS, THE STATE UNIVERSITY | 2002-03-07 | — | — | US | claimed |
| CN-1270804-A | use of diphenyl styrene in cosmetic composition as deodoring active content | OREAL (FR) | 2000-10-25 | — | — | CN | claimed |
| EP-1029530-A1 | Use of 3-substituted stilbene derivatives as deodorizing active principles in cosmetic compositions | L'OREAL (FR) | 2000-08-23 | — | — | EP | claimed |
| CN-1196245-A | Application of stilbene compound and its derivative in preparation of endothelium element antagonist agent | AIR FORCE GENERAL HOSPITAL PLA (CN) | 1998-10-21 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139650-A1 | Fungicidally Active Polymer Dispersions And Use Thereof | CBR3, CBR1, CYP3A4 | LCK 4853/4885PTGS1 3517/4885KDM4E 1199/4885 |
| US-20020198159-A1 | USE OF STILBENE DERIVATIVES SUBSTITUTED IN POSITION 3 AS DEODORANT ACTIVE AGENTS IN COSMETIC COMPOSITIONS | DDT, HAAO, HDHD5 | LCK 2166/4885PTGS1 2696/4885KDM4E 1413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.